US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Ryan Vandrey
Recent news which mentions Ryan Vandrey
New Study Reveals One Cannabis Terpene Significantly Reduces THC-Caused Anxiety
April 11, 2024
Tickers
NEWS
Tags
Cannabis Research
Tory Spindle
d/limonene
From
Benzinga
Johns Hopkins Launches $10M Fed-Funded Study Of 10,000 Medical Marijuana Patients: What We Can Expect
December 28, 2023
Tickers
NEWS
Tags
Benzinga
Ryan Vandrey
News
From
Benzinga
Doesn't CBD Counter THC? Not When It Comes To Edibles... Effects Get Worse: Study
February 14, 2023
Tags
Health Care
cannabis edibles
Ryan Vandrey
From
Benzinga
CBD: New Study Finds Wide Evidence Of Mislabeling For Cannabidiol Products
July 22, 2022
Tags
U/S/ Food and Drug Administration
Ryan Vandrey
Substance Abuse and Mental Health Services Administration
From
Benzinga